IP Infusion, a leading provider to disaggregate telecommunications networks for global providers and HFCL, a leading telecom equipment manufacturer and technology provider, announced their partnership to deliver 5G Transport portfolio of products.
The 5G Transport products include Cell Site Router, DU (Distributed Unit) Aggregation Router, and CU (Centralized Unit) Aggregation Router. IP Infusion’s OcNOS® integrated with HFCL-designed high-performance 5G Transport routers will dramatically improve network efficiencies and optimize telecom infrastructure as 5G rollout accelerates.
HFCL is currently investing in a portfolio of 5G products for the Radio Access Network (RAN) and Transport. The transport network of Communication Service Providers (CSPs) needs modernization due to much higher bandwidth per 5G cell site, densification of cell sites in 5G, Ethernet and IP based transport, and new services with stringent latency requirements like Drones, Autonomous Vehicle and Robotics-based precision manufacturing. HFCL is developing 5G transport products for the fronthaul, midhaul and backhaul to help CSPs transform their transport network.
This joint solution gives operators flexible vendor integration options that support affordable 5G access. IP Infusion’s OcNOS® enhanced capabilities are custom designed to seamlessly work with HFCL’s 5G Transport routers to reduce overall equipment and maintenance costs. HFCL will also have access to IP Infusion’s world-class maintenance and technical support.
The 5G Transport router portfolio with IP Infusion’s network OS showcases leading-edge innovations in multiple areas, including segment routing protocol for significantly increased scalability, closed loop automation for continuous analytics optimizing the end user experience, and increased power efficiencies. To detect and prevent security threats, a simplified configuration interface delivers the benefits of maximum server hardening. HFCL managed the full cycle from concept to design to implementation, tailoring the solution for the specific needs of market use cases both for India and global customers.
HFCL’s 5G Transport products are based on merchant silicon, network dis-aggregated architecture, and on open standards like TIP (Telecom Infra Project), and OCP (Open Compute Project).
IP Infusion’s carrier-grade disaggregated networking solutions allow network operators to create innovative services and accelerate new revenue streams. Its validated network operating system, combined with HFCL-designed high-performance 5G Transport routers, supports a diverse range of networking use cases. With HFCL’s and IP Infusion’s advanced support services, network operators can migrate seamlessly to an end-to-end disaggregated networking solution that delivers lower Total Cost of Ownership.
Mahendra Nahata, HFCL Managing Director
This strategic partnership signals a huge step forward in our goal to help operators modernize their 5G transport network which is critical for the successful rollout of 5G services. We are pleased to partner with IP Infusion, and trust their exemplary record of flexibility, reliability and collaboration will equip us to bring a highly efficient and future-proof solution to our market and to the rest of the world.
Atsushi Ogata, President and CEO of IP Infusion
OcNOS® combined with HFCL’s proven hardware will revolutionize India’s telecom industry, allowing for the deployment of new services quickly based on tested, and validated open networking. This strategic partnership will also comply with the Make in India initiative and is a major milestone in bringing open architecture, broad access and innovation as 5G becomes a reality in India and global markets.
